ATE393166T1 - Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen - Google Patents

Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen

Info

Publication number
ATE393166T1
ATE393166T1 AT01945261T AT01945261T ATE393166T1 AT E393166 T1 ATE393166 T1 AT E393166T1 AT 01945261 T AT01945261 T AT 01945261T AT 01945261 T AT01945261 T AT 01945261T AT E393166 T1 ATE393166 T1 AT E393166T1
Authority
AT
Austria
Prior art keywords
bordetella
pertactin
pertussis
parapertussis
bordertella
Prior art date
Application number
AT01945261T
Other languages
German (de)
English (en)
Inventor
Nicole Guiso-Maclouf
Caroline Boursaux-Eude
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE393166T1 publication Critical patent/ATE393166T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT01945261T 2000-05-25 2001-05-23 Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen ATE393166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25

Publications (1)

Publication Number Publication Date
ATE393166T1 true ATE393166T1 (de) 2008-05-15

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01945261T ATE393166T1 (de) 2000-05-25 2001-05-23 Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen

Country Status (11)

Country Link
US (3) US7070779B2 (https=)
EP (1) EP1284993B1 (https=)
JP (1) JP2003533990A (https=)
AT (1) ATE393166T1 (https=)
AU (1) AU2001267527A1 (https=)
CY (1) CY1110430T1 (https=)
DE (1) DE60133734T2 (https=)
DK (1) DK1284993T3 (https=)
ES (1) ES2303833T3 (https=)
PT (1) PT1284993E (https=)
WO (1) WO2001090143A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
DK1284993T3 (da) 2000-05-25 2008-07-28 Pasteur Institut Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater
WO2008146830A1 (ja) 2007-05-28 2008-12-04 The Kitasato Institute パラ百日咳菌全菌体ワクチン組成物
CU23679A1 (es) 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
EP2430040A1 (en) * 2009-05-11 2012-03-21 Novartis AG Antigen purification process for pertactin antigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
PL2670432T3 (pl) * 2011-02-04 2021-10-11 Zoetis Services Llc Kompozycje immunogenne Bordetella bronchiseptica
CA2826058C (en) * 2011-02-04 2017-06-06 Zoetis Llc Compositions for canine respiratory disease complex
CN109879942A (zh) * 2019-03-01 2019-06-14 浙江省农业科学院 一种兔波氏杆菌外膜蛋白及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
DK1284993T3 (da) 2000-05-25 2008-07-28 Pasteur Institut Polypeptider der indeholder polymorfier af repeat-regionerne i pertactin fra bordetella pertussis, bordetella parapertussis og bordetella bronchiseptica, anvendelse deraf i diagnostik og i immunogene præparater

Also Published As

Publication number Publication date
PT1284993E (pt) 2008-06-11
DE60133734D1 (de) 2008-06-05
EP1284993A2 (en) 2003-02-26
EP1284993B1 (en) 2008-04-23
US20040166116A9 (en) 2004-08-26
WO2001090143A3 (en) 2002-09-26
US20060008474A1 (en) 2006-01-12
JP2003533990A (ja) 2003-11-18
WO2001090143A2 (en) 2001-11-29
AU2001267527A1 (en) 2001-12-03
CY1110430T1 (el) 2012-05-23
DE60133734T2 (de) 2009-05-14
US7070779B2 (en) 2006-07-04
ES2303833T3 (es) 2008-09-01
US20020192237A1 (en) 2002-12-19
DK1284993T3 (da) 2008-07-28
US6964767B2 (en) 2005-11-15
US7314910B2 (en) 2008-01-01
US20030180307A1 (en) 2003-09-25

Similar Documents

Publication Publication Date Title
DK1660528T3 (da) Mutein af tåre-lipocalin
MXPA02009567A (es) Benzoilpirzoles y su uso como herbicidas.
DK0681571T3 (da) Spiro-substituerede azacykliske forbindelser som tachykininreceptorantagonister
ATE393166T1 (de) Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
WO2003093269A3 (de) Substituierte pyrazolo-pyrimidin-4-one
BR0108058A (pt) Corpo maciço
ATE128974T1 (de) Neue kondensierte heterocyclische verbindungen und ihre verwendung für heilmittel.
BR0108711A (pt) Expressão heteróloga de proteìnas de neisseria
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
EA200201214A1 (ru) Замещенные тиоацетамиды
ATE243992T1 (de) Kosmetische zusammensetzung und deren verwendung als hautreinigungsmaske
ATE526994T1 (de) Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
DE50202504D1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DE60131982D1 (de) Veränderte borrelia burgdorferi ospa
DE60140972D1 (de) Antigene aus Cryptosporidium parvum, Antikörper dagegen und diagnostische und therapeutische Zusammensetzungen
EP1147212A4 (en) AUXILIARY T LYMPHOCYTE EPITOPES
DK0589949T3 (da) Hidtil ukendte peptider, fremgangsmåder til fremstilling heraf og anvendelse af disse
BR0210493A (pt) Composição, e, método para remover cerume humano
DE602004024442D1 (de) Weisser fester photoinitiator in form eines pulvers und dessen herstellung
ATE420951T1 (de) Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen
MXPA02012015A (es) Ligandos de receptores para integrinas.
SE0201207D0 (sv) A process for production of a regioselective membrane
Chapman et al. Silence at Ramscliffe

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1284993

Country of ref document: EP